OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00240758

Do-Fluoride New Materials Co Ltd

Commodity ChemicalsVerified

The company’s capital structure is moderately leveraged, with a debt-to-equity ratio of 0.91, indicating a balanced mix of debt and equity financing. Liquidity is assessed as medium, with a current ratio of 1.3, suggesting the company can cover short-term obligations but with limited buffer. Free cash flow is negative at -286.5 million CNY, driven by capital expenditures of -1.06 billion CNY, which reflects ongoing investment in operations. Profitability metrics show a return on equity (ROE) of 2.53% and a return on assets (ROA) of 0.85%, both below the typical thresholds for high-margin chemical producers. Gross profit of 1.3 billion CNY represents 13.8% of revenue, while operating income of 215.9 million CNY accounts for 2.3% of revenue, indicating thin margins and potential cost pressures. Geographically, the company’s revenue is concentrated in China, with no disclosed international operations. Segment-wise, it operates as a single business unit focused on fluoride chemicals, with no material diversification across product lines or markets. Growth appears modest, with revenue of 9.43 billion CNY in the latest period. Analysts have assigned a mean price target of 39.00 CNY, with a strong-buy recommendation from two analysts and no hold or sell ratings. However, the company’s free cash flow and capital expenditure trends suggest reinvestment rather than rapid expansion. Risk factors include medium liquidity risk due to a current ratio of 1.3 and a negative net cash position after subtracting total debt. Dilution risk is low, with no difference between basic and diluted shares outstanding. The company’s capital expenditures and negative free cash flow may signal near-term financial strain if revenue growth does not accelerate. Recent events include no material filings or transcripts, but the company’s capital structure and operating cash flow suggest a focus on maintaining operational capacity rather than aggressive growth. Analysts remain cautiously optimistic, but the lack of diversification and thin margins could limit upside.

30-day price · 002407+13.42 (+49.0%)
Low$26.56High$43.89Close$40.81As of22 May, 00:00 UTC
Profile
CompanyDo-Fluoride New Materials Co Ltd
Ticker002407.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Do-Fluoride New Materials Co Ltd produces and sells fluoride-based chemical products, primarily serving the metallurgy, electronics, and pharmaceutical industries.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92.

The company’s capital structure is moderately leveraged, with a debt-to-equity ratio of 0.91, indicating a balanced mix of debt and equity financing. Liquidity is assessed as medium, with a current ratio of 1.3, suggesting the company can cover short-term obligations but with limited buffer. Free cash flow is negative at -286.5 million CNY, driven by capital expenditures of -1.06 billion CNY, which reflects ongoing investment in operations. Profitability metrics show a return on equity (ROE) of 2.53% and a return on assets (ROA) of 0.85%, both below the typical thresholds for high-margin chemical producers. Gross profit of 1.3 billion CNY represents 13.8% of revenue, while operating income of 215.9 million CNY accounts for 2.3% of revenue, indicating thin margins and potential cost pressures. Geographically, the company’s revenue is concentrated in China, with no disclosed international operations. Segment-wise, it operates as a single business unit focused on fluoride chemicals, with no material diversification across product lines or markets. Growth appears modest, with revenue of 9.43 billion CNY in the latest period. Analysts have assigned a mean price target of 39.00 CNY, with a strong-buy recommendation from two analysts and no hold or sell ratings. However, the company’s free cash flow and capital expenditure trends suggest reinvestment rather than rapid expansion. Risk factors include medium liquidity risk due to a current ratio of 1.3 and a negative net cash position after subtracting total debt. Dilution risk is low, with no difference between basic and diluted shares outstanding. The company’s capital expenditures and negative free cash flow may signal near-term financial strain if revenue growth does not accelerate. Recent events include no material filings or transcripts, but the company’s capital structure and operating cash flow suggest a focus on maintaining operational capacity rather than aggressive growth. Analysts remain cautiously optimistic, but the lack of diversification and thin margins could limit upside.
Key takeaways
  • The company maintains a balanced debt-to-equity ratio of 0.91, but liquidity is constrained with a current ratio of 1.3.
  • Profitability is weak, with ROE of 2.53% and ROA of 0.85%, reflecting low-margin operations.
  • Revenue is concentrated in a single business segment and geographic market, increasing exposure to local economic shifts.
  • Analysts are optimistic, with a mean price target of 39.00 CNY and a strong-buy rating, but free cash flow is negative.
  • Capital expenditures of -1.06 billion CNY suggest ongoing investment, but may strain liquidity if not offset by revenue growth.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$9.43B
Gross profit$1.30B
Operating income$215.9M
Net income$212.8M
R&D
SG&A
D&A
SBC
Operating cash flow$199.1M
CapEx-$1.06B
Free cash flow-$286.5M
Total assets$24.92B
Total liabilities$16.52B
Total equity$8.40B
Cash & equivalents
Long-term debt$7.61B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$8.40B
Net cash-$7.61B
Current ratio1.3
Debt/Equity0.9
ROA0.9%
ROE2.5%
Cash conversion94.0%
CapEx/Revenue-11.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002407Activity
Op margin2.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin2.3%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin13.8%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-11.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity91.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target39.00 CNY
Median price target39.00 CNY
High price target39.00 CNY
Low price target39.00 CNY
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.56 CNY
Last actual EPS0.18 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 01:24 UTCJob: 0cab23d7